News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,058 Results
Type
Article (87237)
Company Profile (722)
Press Release (770072)
Multimedia
Podcasts (163)
Webinars (25)
Section
Business (232974)
Career Advice (4136)
Deals (39782)
Drug Delivery (133)
Drug Development (91204)
Employer Resources (201)
FDA (18247)
Job Trends (17387)
News (397201)
Policy (39896)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (34)
Allergies (118)
Alliances (56979)
ALS (135)
Alzheimer's disease (1642)
Antibody-drug conjugate (ADC) (204)
Approvals (18240)
Artificial intelligence (453)
Autoimmune disease (48)
Automation (23)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (146)
Biotechnology (483)
Bladder cancer (118)
Brain cancer (46)
Breast cancer (435)
Cancer (3527)
Cardiovascular disease (308)
Career advice (3550)
Career pathing (36)
CAR-T (229)
CDC (47)
Cell therapy (627)
Cervical cancer (29)
Clinical research (74919)
Collaboration (1281)
Company closure (4)
Compensation (860)
Complete response letters (50)
COVID-19 (2941)
CRISPR (77)
C-suite (504)
Cystic fibrosis (130)
Data (3750)
Decentralized trials (2)
Denatured (58)
Depression (97)
Diabetes (418)
Diagnostics (7045)
Digital health (30)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (214)
Drug pricing (169)
Drug shortages (36)
Duchenne muscular dystrophy (183)
Earnings (98636)
Editorial (52)
Employer branding (25)
Employer resources (169)
Events (132409)
Executive appointments (955)
FDA (20470)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1132)
Gene editing (164)
Generative AI (44)
Gene therapy (495)
GLP-1 (991)
Government (5347)
Grass and pollen (7)
Guidances (333)
Healthcare (20934)
HIV (48)
Huntington's disease (33)
IgA nephropathy (52)
Immunology and inflammation (223)
Immuno-oncology (17)
Indications (46)
Infectious disease (3159)
Inflammatory bowel disease (179)
Inflation Reduction Act (13)
Influenza (87)
Intellectual property (160)
Interviews (814)
IPO (17922)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (69)
Layoffs (624)
Leadership (30)
Legal (10144)
Liver cancer (89)
Longevity (12)
Lung cancer (511)
Lymphoma (251)
Machine learning (22)
Management (65)
Manufacturing (559)
MASH (117)
Medical device (14827)
Medtech (14845)
Mergers & acquisitions (22675)
Metabolic disorders (1067)
Multiple sclerosis (117)
NASH (23)
Neurodegenerative disease (182)
Neuropsychiatric disorders (49)
Neuroscience (2533)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (54)
Obesity (537)
Opinion (303)
Ovarian cancer (114)
Pain (152)
Pancreatic cancer (146)
Parkinson's disease (214)
Partnered (27)
Patents (382)
Patient recruitment (268)
Peanut (56)
People (66056)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23095)
Phase II (32533)
Phase III (24485)
Pipeline (2444)
Policy (278)
Postmarket research (3554)
Preclinical (10429)
Press Release (72)
Prostate cancer (172)
Psychedelics (49)
Radiopharmaceuticals (281)
Rare diseases (598)
Real estate (7411)
Recruiting (76)
Regulatory (27679)
Reports (64)
Research institute (2674)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (64)
Schizophrenia (119)
Series A (186)
Series B (139)
Service/supplier (30)
Sickle cell disease (75)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (40)
Startups (4314)
State (2)
Stomach cancer (17)
Supply chain (94)
Tariffs (82)
The Weekly (103)
Vaccines (1010)
Venture capital (63)
Weight loss (370)
Women's health (56)
Worklife (21)
Date
Today (118)
Last 7 days (485)
Last 30 days (2427)
Last 365 days (33888)
2025 (23597)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (78)
Alaska (7)
Arizona (295)
Arkansas (14)
Asia (50789)
Australia (8922)
California (8894)
Canada (2697)
China (835)
Colorado (375)
Connecticut (395)
Delaware (239)
Europe (116649)
Florida (1310)
Georgia (303)
Hawaii (3)
Idaho (67)
Illinois (787)
India (45)
Indiana (427)
Iowa (19)
Japan (267)
Kansas (121)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1215)
Massachusetts (6704)
Michigan (295)
Minnesota (541)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (102)
New Hampshire (76)
New Jersey (2453)
New Mexico (31)
New York (2420)
North Carolina (1360)
North Dakota (10)
Northern California (3950)
Ohio (280)
Oklahoma (18)
Oregon (49)
Pennsylvania (1854)
Puerto Rico (18)
Rhode Island (44)
South America (1655)
South Carolina (45)
South Dakota (1)
Southern California (3383)
Tennessee (142)
Texas (1390)
United States (33002)
Utah (265)
Virginia (238)
Washington D.C. (82)
Washington State (762)
West Virginia (4)
Wisconsin (91)
There are 858,058 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hemostemix to Present Its Clinical Data of the Treatment of Severe Angina
September 16, 2025
·
9 min read
Gene therapy
Doctors Still Prescribing Sarepta’s DMD Gene Therapy After Safety Concerns
A new analyst survey suggests that doctors are still prescribing Sarepta’s Elevidys, even after a series of deaths in certain populations marred the gene therapy’s record.
September 16, 2025
·
3 min read
·
Annalee Armstrong
Obesity
Novo’s Amylin Injectable Cagrilintide Hits 11.8% Weight Reduction in Phase III Trial
The sub-analysis, presented at the European Association for the Study of Diabetes congress, showed improved safety data to counteract past tolerability issues.
September 16, 2025
·
2 min read
·
Dan Samorodnitsky
Rare diseases
Stealth, Barth Community Await FDA Verdict With ‘Everything at Stake’
A decade-long journey is coming to an end for Stealth BioTherapeutics and the Barth syndrome community. Will it result in the first-ever treatment for this ultra-rare mitochondrial disease, or possibly the end of the road for the Massachusetts-based biotech?
September 16, 2025
·
6 min read
·
Heather McKenzie
Press Releases
Defence Therapeutics Appoints Dr. Amie Phinney as Director
September 16, 2025
·
3 min read
Obesity
Novo, Lilly Jostle For Market Lead in Obesity With New Regulatory Efforts
Both Novo Nordisk and Eli Lilly are eyeing regulatory advancements for their obesity blockbusters as the European Association for the Study of Diabetes’ annual conference continues this week.
September 16, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Defence Therapeutics Completes Fully Subscribed Debenture Units Financing of $2,000,000
September 16, 2025
·
4 min read
Press Releases
Humanized Mouse Model Market Set to Surge USD 250.94 Million by 2034
September 16, 2025
·
1 min read
Drug pricing
Sanofi Joins Growing Group of Pharmas Pulling Back From UK
Merck, Eli Lilly and AstraZeneca have similarly suspended or outright canceled investments in the U.K. in the past week after a sizeable increase in a mandatory levy in the region.
September 16, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Kennedy Names New ACIP Members as Panel Quiets COVID-19 Vaccine Developers Ahead of Meeting
Like the first batch of appointees to the CDC’s vaccine advisory committee, several of the new panelists have documented histories of vaccine and COVID-19 skepticism.
September 16, 2025
·
2 min read
·
Tristan Manalac
1 of 85,806
Next
